Tapewire

Nasdaq · USD

CDNA

CareDx, Inc.

Export transactions ↓
Tapewire entity
4344
SEC CIK
0001217234
Parsed reports
707

Last 12 months

Inside the activity.

0 purchase rows · 26 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202502
Jan 202603
Feb 202601
Mar 202600
Apr 202601
May 202603
Jun 202606
Jul 202604
Aug 202605
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2020 Filed Jan 4, 2020 00:43 UTC
Colon GraceDirector
GrantCommon Stock 326 $0.00 $0.00
Disclosure

SEC source: 0001780354-20-000002 · wf-form4_157809856545889.xml · nonDerivative · entry 1

Colon Grace · CIK 0001780354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,777

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
December 09, 2019 Filed Dec 10, 2019 18:28 UTC
King SashaChief Commercial Officer
SaleCommon Stock 2,126 $21.97 $46,708.22
Disclosure

SEC source: 0001721150-19-000002 · wf-form4_157602047802403.xml · nonDerivative · entry 1

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,709

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
December 03, 2019 Filed Dec 5, 2019 20:22 UTC SaleCommon Stock 12,500 $20.06 $250,761.25
Disclosure

SEC source: 0000899243-19-028627 · doc4.xml · nonDerivative · entry 1

HAGSTROM WILLIAM A · CIK 0001042875 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,385

Read SEC document
November 26, 2019 Filed Nov 27, 2019 20:32 UTC
Seeto ReginaldSee Remarks
Tax withholdingCommon Stock 4,137 $20.34 $84,146.58
Disclosure

SEC source: 0001688485-19-000002 · wf-form4_157490474476819.xml · nonDerivative · entry 1

Seeto Reginald · CIK 0001688485 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,863

F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of vested restricted stock units.

Read SEC document
October 01, 2019 Filed Oct 2, 2019 17:35 UTC GrantCommon Stock 541 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-024749 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,650

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
October 01, 2019 Filed Oct 2, 2019 21:19 UTC GrantCommon Stock 80 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-024741 · doc4.xml · nonDerivative · entry 1

COURNOYER CHRISTINE · CIK 0001180466 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,653

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
October 01, 2019 Filed Oct 2, 2019 21:23 UTC
Colon GraceDirector
GrantCommon Stock 270 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-024747 · doc4.xml · nonDerivative · entry 1

Colon Grace · CIK 0001780354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,451

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
October 01, 2019 Filed Oct 2, 2019 21:20 UTC GrantCommon Stock 848 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-024743 · doc4.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,741

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
October 01, 2019 Filed Oct 2, 2019 21:20 UTC GrantCommon Stock 541 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-024744 · doc4.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,004

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
September 01, 2019 Filed Sep 4, 2019 01:16 UTC GrantEmployee Stock Option (right to buy) · Derivative 10,301 $0.00 Strike: $22.82 $0.00
Disclosure

SEC source: 0000899243-19-022688 · doc4.xml · derivative · entry 2

COURNOYER CHRISTINE · CIK 0001180466 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,301

Underlying: Common Stock · 10,301 shares

Expires 2029-09-01

F2 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest on October 1, 2019 and 1/36th of the shares subject to the option shall vest monthly thereafter.

Read SEC document
September 01, 2019 Filed Sep 4, 2019 01:16 UTC GrantCommon Stock 6,573 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-022688 · doc4.xml · nonDerivative · entry 1

COURNOYER CHRISTINE · CIK 0001180466 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,573

F1 · shares: The reported securities are represented by restricted stock units, 1/3rd of which shall vest on September 1, 2020 and 1/3rd of which shall vest on each anniversary thereafter.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 16:10 UTC
King SashaChief Commercial Officer
GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-021358 · doc4.xml · nonDerivative · entry 1

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,835

F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on August 6, 2020 and 1/4th of which shall vest on each anniversary thereafter.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 16:11 UTC
Seeto ReginaldSee Remarks
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-021360 · doc4.xml · nonDerivative · entry 1

Seeto Reginald · CIK 0001688485 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on August 6, 2020 and 1/4th of which shall vest on each anniversary thereafter.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:10 UTC
Maag PeterDirector · Chief Executive Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-021359 · doc4.xml · nonDerivative · entry 6

Maag Peter · CIK 0001613855 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 439,814

F7 · shares: The reported securities are represented by restricted stock units, 100% of which were vested upon grant.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:10 UTC
Maag PeterDirector · Chief Executive Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-021359 · doc4.xml · nonDerivative · entry 5

Maag Peter · CIK 0001613855 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 389,814

F6 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on August 6, 2020 and 1/4th of which shall vest on each anniversary thereafter.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:10 UTC
Maag PeterDirector · Chief Executive Officer
SaleCommon Stock 5,191 $30.39 $157,754.49
Disclosure

SEC source: 0000899243-19-021359 · doc4.xml · nonDerivative · entry 4

Maag Peter · CIK 0001613855 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,814

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.08 to $31.07, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:10 UTC
Maag PeterDirector · Chief Executive Officer
SaleCommon Stock 25,303 $29.56 $747,956.68
Disclosure

SEC source: 0000899243-19-021359 · doc4.xml · nonDerivative · entry 3

Maag Peter · CIK 0001613855 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,005

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.06 to $30.06, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:10 UTC
Maag PeterDirector · Chief Executive Officer
SaleCommon Stock 8,741 $28.07 $245,359.87
Disclosure

SEC source: 0000899243-19-021359 · doc4.xml · nonDerivative · entry 2

Maag Peter · CIK 0001613855 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,308

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.61 to $28.55, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:10 UTC
Maag PeterDirector · Chief Executive Officer
SaleCommon Stock 10,765 $27.01 $290,762.65
Disclosure

SEC source: 0000899243-19-021359 · doc4.xml · nonDerivative · entry 1

Maag Peter · CIK 0001613855 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 379,049

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.60 to $27.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.

Read SEC document
August 06, 2019 Filed Aug 8, 2019 20:09 UTC
Bell Michael BrianChief Financial Officer
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-021354 · doc4.xml · nonDerivative · entry 1

Bell Michael Brian · CIK 0001702824 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,900

F1 · shares: The reported securities are represented by restricted stock units, 1/4th of which shall vest on August 6, 2020 and 1/4th of which shall vest on each anniversary thereafter.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:27 UTC
Cohen Fred EDirector
Exercise / conversionStock Option (right to buy) · Derivative 5,255 $0.00 Strike: $5.02 $0.00
Disclosure

SEC source: 0000899243-19-019614 · doc4.xml · derivative · entry 6

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,255 shares

Expires 2026-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/12th of the shares subject to the option vested on July 16, 2016 and 1/12th of the shares subject to the option vested monthly thereafter through June 16, 2017.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:27 UTC
Cohen Fred EDirector
Exercise / conversionStock Option (right to buy) · Derivative 5,255 $0.00 Strike: $5.85 $0.00
Disclosure

SEC source: 0000899243-19-019614 · doc4.xml · derivative · entry 5

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,255 shares

Expires 2025-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/12th of the shares subject to the option vested on July 17, 2015 and 1/12th of the shares subject to the option vested monthly thereafter through June 17, 2016

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:27 UTC
Cohen Fred EDirector
Exercise / conversionStock Option (right to buy) · Derivative 5,255 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0000899243-19-019614 · doc4.xml · derivative · entry 4

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,255 shares

Expires 2024-07-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 1/12th of the shares subject to the option vested on August 21, 2014 and 1/12th of the shares subject to the option vested monthly thereafter through July 21, 2015.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:27 UTC
Cohen Fred EDirector
Exercise / conversionCommon Stock 5,255 $5.02 $26,380.10
Disclosure

SEC source: 0000899243-19-019614 · doc4.xml · nonDerivative · entry 3

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:27 UTC
Cohen Fred EDirector
Exercise / conversionCommon Stock 5,255 $5.85 $30,741.75
Disclosure

SEC source: 0000899243-19-019614 · doc4.xml · nonDerivative · entry 2

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,024

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 11, 2019 Filed Jul 15, 2019 20:27 UTC
Cohen Fred EDirector
Exercise / conversionCommon Stock 5,255 $10.00 $52,550.00
Disclosure

SEC source: 0000899243-19-019614 · doc4.xml · nonDerivative · entry 1

Cohen Fred E · CIK 0001339358 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,769

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 21:26 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 250 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0000899243-19-018755 · doc4.xml · derivative · entry 3

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,250

Underlying: Common Stock · 250 shares

Expires 2027-04-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 21:26 UTC
King SashaChief Commercial Officer
SaleCommon Stock 9,542 $35.74 $341,045.39
Disclosure

SEC source: 0000899243-19-018755 · doc4.xml · nonDerivative · entry 2

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,335

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.22 to $36.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 21:26 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 250 $1.00 $250.00
Disclosure

SEC source: 0000899243-19-018755 · doc4.xml · nonDerivative · entry 1

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,877

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 21:24 UTC
Yee James PChief Medical Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 19,875 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0000899243-19-018754 · doc4.xml · derivative · entry 3

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,125

Underlying: Common Stock · 19,875 shares

Expires 2027-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 27, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 21:24 UTC
Yee James PChief Medical Officer
SaleCommon Stock 20,000 $35.65 $712,936.00
Disclosure

SEC source: 0000899243-19-018754 · doc4.xml · nonDerivative · entry 2

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,045

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.25 to $36.56, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 21:24 UTC
Yee James PChief Medical Officer
Exercise / conversionCommon Stock 19,875 $2.30 $45,712.50
Disclosure

SEC source: 0000899243-19-018754 · doc4.xml · nonDerivative · entry 1

Yee James P · CIK 0001421336 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,045

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
July 01, 2019 Filed Jul 2, 2019 21:13 UTC GrantCommon Stock 312 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-018992 · doc4.xml · nonDerivative · entry 1

SNYDERMAN RALPH · CIK 0001178031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,109

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 01:15 UTC GrantCommon Stock 734 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-018993 · doc4.xml · nonDerivative · entry 1

Goldberg Michael · CIK 0001366412 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,893

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 01:12 UTC GrantCommon Stock 468 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-018991 · doc4.xml · nonDerivative · entry 1

Bickerstaff George · CIK 0001329646 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,463

F1 · shares: Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 20:17 UTC
Colon GraceDirector
GrantEmployee Stock Option (right to buy) · Derivative 6,569 $0.00 Strike: $35.87 $0.00
Disclosure

SEC source: 0000899243-19-019153 · doc4.xml · derivative · entry 2

Colon Grace · CIK 0001780354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,569

Underlying: Common Stock · 6,569 shares

Expires 2029-07-01

F2 · derivative.exercise_date: 1/36th of the shares subject to the option shall vest on August 1, 2019 and 1/36th of the shares subject to the option shall vest monthly thereafter.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 20:17 UTC
Colon GraceDirector
GrantCommon Stock 4,181 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-019153 · doc4.xml · nonDerivative · entry 1

Colon Grace · CIK 0001780354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,181

F1 · shares: The reported securities are represented by restricted stock units 1/3rd of which shall vest on July 1, 2020 and 1/3rd of which shall vest on each anniversary thereafter.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 12,500 $0.00 Strike: $12.24 $0.00
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · derivative · entry 13

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 12,500 shares

Expires 2028-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on June 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 833 $0.00 Strike: $6.31 $0.00
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · derivative · entry 12

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,917

Underlying: Common Stock · 833 shares

Expires 2028-01-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,667 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · derivative · entry 11

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,333

Underlying: Common Stock · 1,667 shares

Expires 2027-10-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: 1/4th of the shares subject to the option vested on October 20, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 278 $0.00 Strike: $2.80 $0.00
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · derivative · entry 10

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 278 shares

Expires 2027-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 50% of the shares subject to the option vested on September 1, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 417 $0.00 Strike: $1.07 $0.00
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · derivative · entry 9

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 417 shares

Expires 2027-06-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares subject to the option vested on June 9, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 500 $0.00 Strike: $1.00 $0.00
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · derivative · entry 8

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 500 shares

Expires 2027-04-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares subject to the option vested on March 30, 2018 and 1/48th of the shares subject to the option vest monthly thereafter.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
SaleCommon Stock 30,840 $38.38 $1,183,512.76
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · nonDerivative · entry 7

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,627

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.59 to $40.32, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 12,500 $12.24 $153,000.00
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · nonDerivative · entry 6

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 833 $6.31 $5,256.23
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · nonDerivative · entry 5

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,967

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 1,667 $5.90 $9,835.30
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · nonDerivative · entry 4

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,134

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 278 $2.80 $778.40
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · nonDerivative · entry 3

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 417 $1.07 $446.19
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · nonDerivative · entry 2

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
June 20, 2019 Filed Jun 21, 2019 17:08 UTC
King SashaChief Commercial Officer
Exercise / conversionCommon Stock 500 $1.00 $500.00
Disclosure

SEC source: 0000899243-19-017819 · doc4.xml · nonDerivative · entry 1

King Sasha · CIK 0001721150 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,772

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.